Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ensysce Biosciences Inc.

1.76
-0.1200-6.38%
Post-market: 1.790.0300+1.70%19:55 EDT
Volume:133.33K
Turnover:233.60K
Market Cap:2.89M
PE:-0.15
High:1.82
Open:1.80
Low:1.71
Close:1.88
Loading ...
Mar 31, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2022

Major Issues Report

8-K - Current report
Jan 31, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 27, 2022

Major Issues Report

8-K - Current report
Jan 18, 2022

Major Issues Report

8-K - Current report
Dec 27, 2021

Major Issues Report

8-K - Current report
Nov 01, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 29, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 25, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Oct 12, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 07, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Sep 27, 2021

Major Issues Report

8-K - Current report
Sep 22, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 17, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933